The pta balloon catheter market size has grown rapidly in recent years. It will grow from $2.56 billion in 2025 to $2.85 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, expansion of catheter-based treatment approaches, improvements in angioplasty techniques, wider availability of interventional cardiology services, growing aging population.
The pta balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing adoption of advanced endovascular therapies, rising focus on outpatient vascular procedures, expansion of peripheral artery disease treatment, growing investments in catheter innovation, increasing preference for minimally invasive solutions. Major trends in the forecast period include increasing adoption of drug-coated balloon technologies, rising use of minimally invasive vascular procedures, growing demand for high-precision balloon catheters, expansion of peripheral vascular interventions, enhanced focus on biocompatible catheter materials.
The growing burden of cardiovascular disorders is anticipated to accelerate the expansion of the percutaneous transluminal angioplasty (PTA) balloon catheter sector in the coming years. Cardiovascular disorders include conditions such as peripheral artery disease (PAD), atherosclerosis, and coronary artery disease, all of which are characterized by narrowed or obstructed blood vessels that impede normal blood flow. The rising incidence of these conditions is largely attributed to aging demographics, inactive lifestyles, increasing obesity rates, and associated risk factors such as hypertension and diabetes. As cardiovascular disease prevalence increases, demand rises for minimally invasive vascular interventions that can reopen vessels, enhance blood circulation, and lower the likelihood of serious complications, thereby supporting adoption of PTA balloon catheters. For example, in May 2023, data from the Indiana Department of Health (IDOH) indicated that of the approximately 250,000 central line-associated bloodstream infections (CLABSIs) occurring annually in U.S. hospitals, nearly 80,000 cases are reported within intensive care units (ICUs). Consequently, the escalating prevalence of cardiovascular disorders continues to drive growth in this segment.
Leading participants in the percutaneous transluminal angioplasty (PTA) balloon catheter space are increasingly emphasizing advanced design innovations such as serration technology to improve lesion access, enable more controlled vessel expansion, and deliver better procedural outcomes in complex peripheral artery disease cases. Serration technology involves integrating precisely engineered serrated features on the balloon surface, which create controlled micro-incisions in the vessel wall during inflation. This approach allows for more consistent luminal enlargement while limiting vessel trauma compared with traditional high-pressure balloons. For instance, in February 2025, Cagent Vascular, a United States-based endovascular device manufacturer, introduced the Serranator SL Pro, a next-generation serration-enabled PTA balloon catheter designed for patients with chronic limb-threatening ischemia (CLTI) and pedal artery disease. Utilizing the company’s proprietary serration-based design, the device targets diffuse and heavily calcified lesions by generating longitudinal micro-serrations that support effective vessel dilation at reduced inflation pressures. This launch is intended to enhance vessel preparation in below-the-ankle procedures while lowering dissection risk and decreasing reliance on adjunctive high-pressure interventions.
In November 2023, OrbusNeich Medical Group Holdings Limited, a Hong Kong-based medical device company focused on percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) solutions, completed the acquisition of Eucatech AG for EUR 2.4 million. Through this transaction, OrbusNeich seeks to strengthen its PTA balloon catheter portfolio by incorporating Eucatech’s CE-marked paclitaxel-coated PTA balloons, as well as its range of coronary drug-eluting balloons, self-expandable stents, and sirolimus-eluting coronary stents. Eucatech AG, headquartered in Germany, specializes in minimally invasive cardiovascular and endovascular technologies, with a particular focus on paclitaxel-coated coronary and peripheral PTA balloon products.
Major companies operating in the pta balloon catheter market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Lepu Medical, B. Braun Corporation, Terumo, Nipro Medical, Teleflex, Cook Medical, Biotronik, Merit Medical, Microport Scientific, Cardiovascular Systems, Well Lead Medical, Cardionovum, JOTEC, Creagh Medical, Natec Medical, TriReme Medical, Andratec, Acotec Scientific, Kaneka Corporation.
North America was the largest region in the PTA balloon catheter market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pta balloon catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pta balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pta balloon catheter market by increasing costs of imported polymers, medical-grade nylon, manufacturing equipment, and sterilization materials used in catheter production. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported devices, while Asia-Pacific faces higher export manufacturing costs. These tariffs are increasing device prices and affecting procurement budgets. However, they are also driving local catheter manufacturing, regional material sourcing, and innovation in cost-optimized catheter designs.
The pta balloon catheter market research report is one of a series of new reports that provides pta balloon catheter market statistics, including pta balloon catheter industry global market size, regional shares, competitors with a pta balloon catheter market share, detailed pta balloon catheter market segments, market trends and opportunities, and any further data you may need to thrive in the pta balloon catheter industry. This pta balloon catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A PTA balloon catheter is a medical procedure designed to widen a narrowed vessel opening using a small, flexible plastic tube or catheter with a 'balloon' at its end. This technique is utilized in minimally invasive catheterization procedures.
The primary types of PTA balloon catheters include polyurethane and nylon. Polyurethane is a material derived from plastic in various forms, with applications spanning coronary artery disease and peripheral vascular disease. These catheters find use in various healthcare settings, including hospitals, ambulatory surgical centers, and others.
The PTA balloon catheter market consists of sales of non-compliant (high-pressure) balloons, semi-compliant (mid pressure), and compliant (elastomeric) balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pta balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing adoption of advanced endovascular therapies, rising focus on outpatient vascular procedures, expansion of peripheral artery disease treatment, growing investments in catheter innovation, increasing preference for minimally invasive solutions. Major trends in the forecast period include increasing adoption of drug-coated balloon technologies, rising use of minimally invasive vascular procedures, growing demand for high-precision balloon catheters, expansion of peripheral vascular interventions, enhanced focus on biocompatible catheter materials.
The growing burden of cardiovascular disorders is anticipated to accelerate the expansion of the percutaneous transluminal angioplasty (PTA) balloon catheter sector in the coming years. Cardiovascular disorders include conditions such as peripheral artery disease (PAD), atherosclerosis, and coronary artery disease, all of which are characterized by narrowed or obstructed blood vessels that impede normal blood flow. The rising incidence of these conditions is largely attributed to aging demographics, inactive lifestyles, increasing obesity rates, and associated risk factors such as hypertension and diabetes. As cardiovascular disease prevalence increases, demand rises for minimally invasive vascular interventions that can reopen vessels, enhance blood circulation, and lower the likelihood of serious complications, thereby supporting adoption of PTA balloon catheters. For example, in May 2023, data from the Indiana Department of Health (IDOH) indicated that of the approximately 250,000 central line-associated bloodstream infections (CLABSIs) occurring annually in U.S. hospitals, nearly 80,000 cases are reported within intensive care units (ICUs). Consequently, the escalating prevalence of cardiovascular disorders continues to drive growth in this segment.
Leading participants in the percutaneous transluminal angioplasty (PTA) balloon catheter space are increasingly emphasizing advanced design innovations such as serration technology to improve lesion access, enable more controlled vessel expansion, and deliver better procedural outcomes in complex peripheral artery disease cases. Serration technology involves integrating precisely engineered serrated features on the balloon surface, which create controlled micro-incisions in the vessel wall during inflation. This approach allows for more consistent luminal enlargement while limiting vessel trauma compared with traditional high-pressure balloons. For instance, in February 2025, Cagent Vascular, a United States-based endovascular device manufacturer, introduced the Serranator SL Pro, a next-generation serration-enabled PTA balloon catheter designed for patients with chronic limb-threatening ischemia (CLTI) and pedal artery disease. Utilizing the company’s proprietary serration-based design, the device targets diffuse and heavily calcified lesions by generating longitudinal micro-serrations that support effective vessel dilation at reduced inflation pressures. This launch is intended to enhance vessel preparation in below-the-ankle procedures while lowering dissection risk and decreasing reliance on adjunctive high-pressure interventions.
In November 2023, OrbusNeich Medical Group Holdings Limited, a Hong Kong-based medical device company focused on percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) solutions, completed the acquisition of Eucatech AG for EUR 2.4 million. Through this transaction, OrbusNeich seeks to strengthen its PTA balloon catheter portfolio by incorporating Eucatech’s CE-marked paclitaxel-coated PTA balloons, as well as its range of coronary drug-eluting balloons, self-expandable stents, and sirolimus-eluting coronary stents. Eucatech AG, headquartered in Germany, specializes in minimally invasive cardiovascular and endovascular technologies, with a particular focus on paclitaxel-coated coronary and peripheral PTA balloon products.
Major companies operating in the pta balloon catheter market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Lepu Medical, B. Braun Corporation, Terumo, Nipro Medical, Teleflex, Cook Medical, Biotronik, Merit Medical, Microport Scientific, Cardiovascular Systems, Well Lead Medical, Cardionovum, JOTEC, Creagh Medical, Natec Medical, TriReme Medical, Andratec, Acotec Scientific, Kaneka Corporation.
North America was the largest region in the PTA balloon catheter market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pta balloon catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pta balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pta balloon catheter market by increasing costs of imported polymers, medical-grade nylon, manufacturing equipment, and sterilization materials used in catheter production. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported devices, while Asia-Pacific faces higher export manufacturing costs. These tariffs are increasing device prices and affecting procurement budgets. However, they are also driving local catheter manufacturing, regional material sourcing, and innovation in cost-optimized catheter designs.
The pta balloon catheter market research report is one of a series of new reports that provides pta balloon catheter market statistics, including pta balloon catheter industry global market size, regional shares, competitors with a pta balloon catheter market share, detailed pta balloon catheter market segments, market trends and opportunities, and any further data you may need to thrive in the pta balloon catheter industry. This pta balloon catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A PTA balloon catheter is a medical procedure designed to widen a narrowed vessel opening using a small, flexible plastic tube or catheter with a 'balloon' at its end. This technique is utilized in minimally invasive catheterization procedures.
The primary types of PTA balloon catheters include polyurethane and nylon. Polyurethane is a material derived from plastic in various forms, with applications spanning coronary artery disease and peripheral vascular disease. These catheters find use in various healthcare settings, including hospitals, ambulatory surgical centers, and others.
The PTA balloon catheter market consists of sales of non-compliant (high-pressure) balloons, semi-compliant (mid pressure), and compliant (elastomeric) balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. PTA Balloon Catheter Market Characteristics
3. PTA Balloon Catheter Market Supply Chain Analysis
4. Global PTA Balloon Catheter Market Trends and Strategies
5. PTA Balloon Catheter Market Analysis of End Use Industries
7. Global PTA Balloon Catheter Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global PTA Balloon Catheter Total Addressable Market (TAM) Analysis for the Market
9. PTA Balloon Catheter Market Segmentation
10. PTA Balloon Catheter Market Regional and Country Analysis
11. Asia-Pacific PTA Balloon Catheter Market
12. China PTA Balloon Catheter Market
13. India PTA Balloon Catheter Market
14. Japan PTA Balloon Catheter Market
15. Australia PTA Balloon Catheter Market
16. Indonesia PTA Balloon Catheter Market
17. South Korea PTA Balloon Catheter Market
18. Taiwan PTA Balloon Catheter Market
19. South East Asia PTA Balloon Catheter Market
20. Western Europe PTA Balloon Catheter Market
21. UK PTA Balloon Catheter Market
22. Germany PTA Balloon Catheter Market
23. France PTA Balloon Catheter Market
24. Italy PTA Balloon Catheter Market
25. Spain PTA Balloon Catheter Market
26. Eastern Europe PTA Balloon Catheter Market
27. Russia PTA Balloon Catheter Market
28. North America PTA Balloon Catheter Market
29. USA PTA Balloon Catheter Market
30. Canada PTA Balloon Catheter Market
31. South America PTA Balloon Catheter Market
32. Brazil PTA Balloon Catheter Market
33. Middle East PTA Balloon Catheter Market
34. Africa PTA Balloon Catheter Market
36. PTA Balloon Catheter Market Competitive Landscape and Company Profiles
37. PTA Balloon Catheter Market Other Major and Innovative Companies
40. PTA Balloon Catheter Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
PTA Balloon Catheter Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pta balloon catheter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pta balloon catheter? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pta balloon catheter market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Polyurethane; Nylon2) By Application: Coronary Artery Disease; Peripheral Vascular Disease
3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Polyurethane: Non-compliant Balloons; Compliant Balloons2) By Nylon: Non-compliant Balloons; Compliant Balloons
Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Lepu Medical; B. Braun Corporation; Terumo; Nipro Medical; Teleflex; Cook Medical; Biotronik; Merit Medical; Microport Scientific; Cardiovascular Systems; Well Lead Medical; Cardionovum; JOTEC; Creagh Medical; Natec Medical; TriReme Medical; Andratec; Acotec Scientific; Kaneka Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this PTA Balloon Catheter market report include:- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Lepu Medical
- B. Braun Corporation
- Terumo
- Nipro Medical
- Teleflex
- Cook Medical
- Biotronik
- Merit Medical
- Microport Scientific
- Cardiovascular Systems
- Well Lead Medical
- Cardionovum
- JOTEC
- Creagh Medical
- Natec Medical
- TriReme Medical
- Andratec
- Acotec Scientific
- Kaneka Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.85 Billion |
| Forecasted Market Value ( USD | $ 4.31 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
